The addition of activin A and inhibin A measurement to uterine artery Doppler velocimetry to improve the early prediction of pre-eclampsia

被引:35
作者
Florio, P
Reis, FM
Pezzani, I
Luisi, S
Severi, FM
Petraglia, F
机构
[1] Univ Siena, Chair Obstet & Gynecol, Policlin Le Scotte, I-53100 Siena, Italy
[2] Univ Fed Minas Gerais, Dept Obstet & Gynecol, Belo Horizonte, MG, Brazil
[3] Univ Udine, Dept Surg Sci, Chair Obstet & Gynecol, I-33100 Udine, Italy
关键词
activin; Doppler; inhibin; predictive value; pre-eclampsia;
D O I
10.1002/uog.29
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
Objective To evaluate whether the measurement of maternal serum activin A and inhibin A adds any clinically relevant information for the prediction of pre-eclampsia in women with altered uterine artery Doppler velocimetry at 24 weeks of gestation. Methods This was a prospective, controlled, hospital-based study involving 58 asymptomatic pregnant women at 24 weeks' gestation in whom a diastolic notch of the uterine artery waveform was noted at routine Doppler examination. Doppler assessment of the uterine artery waveform and measurement of maternal activin A and inhibin A serum levels by specific two-site enzyme immunoassays were performed. The cut-off points for defining 'high' serum activin A and inhibin A levels for prediction of pre-eclampsia were chosen by receiver-operating characteristics (ROC) curve analysis. The probability of developing pre-eclampsia was calculated for several combinations of results of hormone testing. Results Activin A and inhibin A levels were higher in patients who developed pre-eclampsia (n = 18; mean standard error: 2.69 +/- 0.35 ng/mL and 131.2 +/- 22.7 pg/mL, respectively) than in those who did not present with pre-eclampsia at follow-up (n 40; activin A: 1.79 +/- 0.18 ng/mL and inhibin A: 91.9 +/- 6.2 pg/mL; P < 0.05). Activin A at the cut-off value of 1.7 multiples of the median (MoM) achieved a sensitivity of 61% and a specificity of 89%, whereas inhibin A at the cut-off value of 1.8 MoM combined a sensitivity of 39% with a specificity of 92% for prediction of pre-eclampsia. The probability of pre-eclampsia was 31% in the whole study population, 86% if both activin A and inhibin A were elevated and 17% if both hormone markers were unaltered. Conclusion The measurement of serum activin A and inhibin A levels may add significant prognostic information for predicting pre-eclampsia in pregnant women showing specific Doppler alterations in the late second trimester. Copyright (C) 2003 ISUOG. Published by John Wiley & Sons, Ltd.
引用
收藏
页码:165 / 169
页数:5
相关论文
共 21 条
  • [1] One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks' gestation
    Albaiges, G
    Missfelder-Lobos, H
    Lees, C
    Parra, M
    Nicolaides, KH
    [J]. OBSTETRICS AND GYNECOLOGY, 2000, 96 (04) : 559 - 564
  • [2] Second-trimester maternal serum inhibin A concentration as an early marker for preeclampsia
    Aquilina, J
    Barnett, A
    Thompson, O
    Harrington, K
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 181 (01) : 131 - 136
  • [3] Improved early prediction of pre-eclampsia by combining second-trimester maternal serum inhibin-A and uterine artery Doppler
    Aquilina, J
    Thompson, O
    Thilaganathan, B
    Harrington, K
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2001, 17 (06) : 477 - 484
  • [4] CAMPBELL S, 1986, OBSTET GYNECOL, V68, P649
  • [5] How useful is uterine artery Doppler flow velocimetry in the prediction of pre-eclampsia, intrauterine growth retardation and perinatal death? An overview
    Chien, PFW
    Arnott, N
    Gordon, A
    Owen, P
    Khan, KS
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2000, 107 (02): : 196 - 208
  • [6] Increased maternal serum activin A but not follistatin levels in pregnant women with hypertensive disorders
    D'Antona, D
    Reis, FM
    Benedetto, C
    Evans, LW
    Groome, NP
    de Kretser, DM
    Wallace, EM
    Petraglia, F
    [J]. JOURNAL OF ENDOCRINOLOGY, 2000, 165 (01) : 157 - 162
  • [7] Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy
    Gifford, RW
    August, PA
    Cunningham, G
    Green, LA
    Lindheimer, MD
    McNellis, D
    Roberts, JM
    Sibai, BM
    Taler, SJ
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 183 (01) : S1 - S22
  • [8] Serum levels of activin A and inhibin A and the subsequent development of preeclampsia
    Grobman, WA
    Wang, EY
    [J]. OBSTETRICS AND GYNECOLOGY, 2000, 96 (03) : 390 - 394
  • [9] DETECTION OF DIMERIC INHIBIN THROUGHOUT THE HUMAN MENSTRUAL-CYCLE BY 2-SITE ENZYME-IMMUNOASSAY
    GROOME, NP
    ILLINGWORTH, PJ
    OBRIEN, M
    COOKE, I
    GANESAN, TS
    BAIRD, DT
    MCNEILLY, AS
    [J]. CLINICAL ENDOCRINOLOGY, 1994, 40 (06) : 717 - 723
  • [10] Development and application of a two-site enzyme immunoassay for the determination of 'total' activin-A concentrations in serum and follicular fluid
    Knight, PG
    Muttukrishna, S
    Groome, NP
    [J]. JOURNAL OF ENDOCRINOLOGY, 1996, 148 (02) : 267 - 279